(2S)-2-[[(1R,4E,6R)-6-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxy-1-methylcyclooct-4-ene-1-carbonyl]amino]butanedioic acid
C54H86N6O14 — CID 162728377
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-[[(1R,4E,6R)-6-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxy-1-methylcyclooct-4-ene-1-carbonyl]amino]butanedioic acid
(2S)-2-[[(1R,4E,6R)-6-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxy-1-methylcyclooct-4-ene-1-carbonyl]amino]butanedioic acid (PubChem CID 162728377) has the molecular formula C54H86N6O14 and a molecular weight of 1043.31 g/mol. Its IUPAC name is (2S)-2-[[(1R,4E,6R)-6-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxy-1-methylcyclooct-4-ene-1-carbonyl]amino]butanedioic acid.
Molecular Properties
| Compound Name | (2S)-2-[[(1R,4E,6R)-6-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxy-1-methylcyclooct-4-ene-1-carbonyl]amino]butanedioic acid |
|---|---|
| PubChem CID | 162728377 |
| Molecular Formula | C54H86N6O14 |
| Molecular Weight | 1043.31 g/mol |
| Exact Mass | 1042.62 |
| IUPAC Name | (2S)-2-[[(1R,4E,6R)-6-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxy-1-methylcyclooct-4-ene-1-carbonyl]amino]butanedioic acid |
| SMILES | CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)O[C@H]1/C=C\CC[C@@](C)(C(=O)N[C@@H](CC(=O)O)C(=O)O)CC1)C(C)C |
| InChI | InChI=1S/C54H86N6O14/c1-14-33(6)45(40(72-12)30-41(61)60-28-20-24-39(60)47(73-13)34(7)48(65)55-35(8)46(64)36-21-16-15-17-22-36)58(10)50(67)43(31(2)3)57-49(66)44(32(4)5)59(11)53(71)74-37-23-18-19-26-54(9,27-25-37)52(70)56-38(51(68)69)29-42(62)63/h15-18,21-23,31-35,37-40,43-47,64H,14,19-20,24-30H2,1-13H3,(H,55,65)(H,56,70)(H,57,66)(H,62,63)(H,68,69)/b23-18-/t33-,34+,35+,37-,38-,39-,40+,43-,44-,45-,46+,47+,54+/m0/s1 |
| InChIKey | MPAQEANQHFKXKN-BZIFTLHRSA-N |
| XLogP | 4.93 |
| TPSA | 270.75 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1043.31 |
| LogP ≤ 5 | 4.93 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162728377 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.